, Volume 5, Issue 3, pp 217-227
Date: 25 Aug 2010

Immune therapeutic targeting of glioma cancer stem cells

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Glioblastoma multiforme (GBM) is a lethal cancer that responds poorly to radiotherapy and chemotherapy. Glioma cancer stem cells (gCSCs) have been shown to recapitulate the characteristic features of GBM and to mediate chemotherapy and radiation resistance. Immunotherapeutic targeting of this cell population holds therapeutic promise but must be considered in the context of the immunosuppressive properties mediated by the gCSC. Recent findings have indicated that this goal will be challenging because the gCSC can suppress both the innate and adaptive immune systems by a variety of gCSC-secreted products and cell-membrane interactions. In this review article, we will attempt to reconcile the disparate research findings regarding the potential of immune targeting of the gCSC and propose several novel solutions.

Mustafa Aziz Hatiboglu, Jun Wei and Adam Sauh Gee Wu were Co-lead authors